Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. BHRB
BHRB logo

BHRB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Burke & Herbert Financial Services Corp (BHRB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
62.680
1 Day change
1.16%
52 Week Range
70.900
Analysis Updated At
2026/03/13
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Burke & Herbert Financial Services Corp (BHRB) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock is oversold based on RSI, the lack of positive trading signals, neutral sentiment from hedge funds and insiders, and a recent downgrade in analyst ratings suggest that waiting for a more favorable entry point would be prudent. The company's financial performance shows some positive growth in net income and EPS, but the slight revenue decline and lack of recent news catalysts do not support immediate action.

Technical Analysis

The technical indicators show a mixed picture. The RSI is at 19.61, indicating the stock is oversold, which could suggest a potential rebound. However, the MACD histogram is negative (-0.519) and contracting, signaling bearish momentum. Moving averages are converging, showing no clear trend. The stock is trading near its S1 support level (61.497), with resistance levels at 63.772 and 66.047.

Positive Catalysts

  • The stock is oversold based on RSI, which could indicate a potential rebound. The company's net income and EPS have shown positive YoY growth in the latest quarter.

Neutral/Negative Catalysts

  • The MACD is bearish, and the stock is trading near its support level, indicating potential downside risk. Analysts have downgraded the stock to Hold, citing valuation concerns. There is no recent news or significant trading activity from hedge funds or insiders to act as a catalyst.

Financial Performance

In Q3 2025, the company reported a slight revenue decline of -0.55% YoY to $81.86 million. However, net income increased by 8.55% YoY to $29.739 million, and EPS grew by 8.24% YoY to 1.97. This indicates some positive growth trends despite the revenue drop.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts recently downgraded the stock to Hold from Buy, with price targets of $74 and $75, citing valuation concerns after the company exceeded expectations in Q4. The downgrade reflects a cautious outlook despite the company's strong performance.

Wall Street analysts forecast BHRB stock price to rise
1 Analyst Rating
Wall Street analysts forecast BHRB stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 61.960
sliders
Low
74
Averages
74
High
74
Current: 61.960
sliders
Low
74
Averages
74
High
74
Freedom Capital
Buy
to
Hold
downgrade
$73 -> $74
AI Analysis
2026-02-25
Reason
Freedom Capital
Price Target
$73 -> $74
AI Analysis
2026-02-25
downgrade
Buy
to
Hold
Reason
Freedom Capital downgraded Burke & Herbert (BHRB) to Hold from Buy with a price target of $74, up from $73, citing valuation after the company topped the firm's expectations on both earnings and revenue in Q4. The firm's updated valuation incorporates the impact of the LinkBancorp (LNKB) merger beginning in Q2, the analyst noted.
DA Davidson
Neutral
initiated
$75
2026-02-24
Reason
DA Davidson
Price Target
$75
2026-02-24
initiated
Neutral
Reason
DA Davidson initiated coverage of Burke & Herbert with a Neutral rating and $75 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BHRB
Unlock Now

People Also Watch